Singapore Markets closed
Straits Times Index
3,258.90 +1.72 (+0.05%) Nikkei
28,041.48 +258.55 (+0.93%) Hang Seng
20,400.11 +90.98 (+0.45%) FTSE 100
7,631.74 +11.31 (+0.15%) Bitcoin USD
28,575.41 +438.99 (+1.56%) CMC Crypto 200
621.79 +7.58 (+1.23%)
Orphazyme A/S (ORPHA.CO)
Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
At close: 04:06PM CEST
| Previous close | 0.7700 |
| Open | 0.8085 |
| Bid | 0.8075 x 0 |
| Ask | 0.8080 x 0 |
| Day's range | 0.7725 - 0.8090 |
| 52-week range | 0.7035 - 5.4500 |
| Volume | |
| Avg. volume | 43,798 |
| Market cap | 28.515M |
| Beta (5Y monthly) | 0.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -17.0100 |
| Earnings date | 28 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
© 2023 Yahoo. All rights reserved.
